HOME > News > Press Releases > 2024.7.23 Glac Biotech Unveils Next-Generation Probiotic Technology and Brain Health Innovations
2024.7.23 Glac Biotech Unveils Next-Generation Probiotic Technology and Brain Health Innovations
The doors of the Nangang Exhibition Center swung open this July, buzzing with the energy of innovators from across Asia. Amid the sea of booths and banners, one stood out not only for its science, but for its story — Glac Biotech, Taiwan’s own pioneer, and the only company here holding an FDA GRAS-certified probiotic strain.
At booth J216, visitors didn’t just see products. They stepped into a glimpse of the future. Glac was there to showcase something game-changing: its proprietary PRONEX® and PRIMETEK® technologies, and a bold new category of research — probiotics designed for the brain. Alongside the science, Glac had a message for partners: “We’re not just innovating, we’re inviting you to be part of this journey.” To mark the occasion, special offers awaited every client who joined hands during the exhibition — a token of gratitude, but also a spark to push the entire probiotic market forward.
The Dawn of Brain Probiotics
Imagine probiotics not only nurturing the gut, but also supporting the mind. Glac Biotech’s team presented years of research into how gut flora balance can influence brain health. Their formulation combined four powerful Bifidobacterium strains — B. infantis BLI-02, B. breve Bv-889, B. lactis CP-9, B. bifidum VDD088 — with a remarkable discovery: Lactobacillus plantarum PL-02, sourced from the gut of an Olympic athlete. Together, this elite lineup formed a new frontier: a blend that connects gut balance to cognitive wellness. For scientists, it was data. For parents, professionals, and patients, it was hope.
The Power Behind the Innovation: PRONEX® and PRIMETEK®
Behind every strain lies a story of protection and precision. Glac’s PRONEX® manufacturing platform was engineered to eliminate human error with automated remote control systems. Its patented microencapsulation shields fragile bacteria, while a smart rapid-cooling technology — co-developed with global leaders — locks in freshness and viability from start to finish. The result? Probiotics that don’t just survive production, they thrive until they reach the human body.
Then there’s PRIMETEK®, Glac’s professional one-stop ODM solution. It doesn’t stop at raw materials — it covers everything from strain development, formulation, and production to finished consumer-ready products. Every step is backed by international certifications, rigorous quality control, and data-driven validation. Together, PRONEX® and PRIMETEK® don’t just give clients a supplier — they give them a partner in creating probiotic champions.
Riding the Wave of Global Growth
The timing couldn’t be better. Taiwan’s probiotic market is booming, riding the surge of global momentum. In 2023, the world’s probiotic industry was valued at USD 88 billion. By 2031, it’s projected to hit USD 134.88 billion — a CAGR of 6.29% from 2024 to 2031. These aren’t just numbers; they are proof that consumers everywhere are seeking solutions that strengthen health, and that the stage is set for leaders like Glac to drive the industry forward.
Beyond the Gut — Towards a Healthier World
Probiotics are already household names for gut health and immunity. But Glac Biotech sees more. With relentless R&D and groundbreaking processes, the company is opening doors to new applications — from digestion, to immunity, to brain health and beyond.
For Glac, the BioAsia 2024 showcase was not just an exhibition. It was a declaration: that innovation, trust, and vision can come together to the world’s next generation of probiotic champions.
At booth J216, visitors didn’t just see products. They stepped into a glimpse of the future. Glac was there to showcase something game-changing: its proprietary PRONEX® and PRIMETEK® technologies, and a bold new category of research — probiotics designed for the brain. Alongside the science, Glac had a message for partners: “We’re not just innovating, we’re inviting you to be part of this journey.” To mark the occasion, special offers awaited every client who joined hands during the exhibition — a token of gratitude, but also a spark to push the entire probiotic market forward.
The Dawn of Brain Probiotics
Imagine probiotics not only nurturing the gut, but also supporting the mind. Glac Biotech’s team presented years of research into how gut flora balance can influence brain health. Their formulation combined four powerful Bifidobacterium strains — B. infantis BLI-02, B. breve Bv-889, B. lactis CP-9, B. bifidum VDD088 — with a remarkable discovery: Lactobacillus plantarum PL-02, sourced from the gut of an Olympic athlete. Together, this elite lineup formed a new frontier: a blend that connects gut balance to cognitive wellness. For scientists, it was data. For parents, professionals, and patients, it was hope.
The Power Behind the Innovation: PRONEX® and PRIMETEK®
Behind every strain lies a story of protection and precision. Glac’s PRONEX® manufacturing platform was engineered to eliminate human error with automated remote control systems. Its patented microencapsulation shields fragile bacteria, while a smart rapid-cooling technology — co-developed with global leaders — locks in freshness and viability from start to finish. The result? Probiotics that don’t just survive production, they thrive until they reach the human body.
Then there’s PRIMETEK®, Glac’s professional one-stop ODM solution. It doesn’t stop at raw materials — it covers everything from strain development, formulation, and production to finished consumer-ready products. Every step is backed by international certifications, rigorous quality control, and data-driven validation. Together, PRONEX® and PRIMETEK® don’t just give clients a supplier — they give them a partner in creating probiotic champions.
Riding the Wave of Global Growth
The timing couldn’t be better. Taiwan’s probiotic market is booming, riding the surge of global momentum. In 2023, the world’s probiotic industry was valued at USD 88 billion. By 2031, it’s projected to hit USD 134.88 billion — a CAGR of 6.29% from 2024 to 2031. These aren’t just numbers; they are proof that consumers everywhere are seeking solutions that strengthen health, and that the stage is set for leaders like Glac to drive the industry forward.
Beyond the Gut — Towards a Healthier World
Probiotics are already household names for gut health and immunity. But Glac Biotech sees more. With relentless R&D and groundbreaking processes, the company is opening doors to new applications — from digestion, to immunity, to brain health and beyond.
For Glac, the BioAsia 2024 showcase was not just an exhibition. It was a declaration: that innovation, trust, and vision can come together to the world’s next generation of probiotic champions.
Media Coverage (Extended Reading)
Commercial Times (CTEE) — Jul 23, 2024 (Chinese)
https://www.ctee.com.tw/news/20240723701398-431205
-
2025.7.9 Glac Biotech Donates Probiotics to Support Vulnerable Communities in Changhua
-
2025.08.07 Taiwan’s First GRAS-Certified Probiotic — Glac Biotech’s MP108 Achieves Historic U.S. FDA Recognition
-
2024.9.5 Glac Biotech Brings Hope to Guangfu Elementary — A Story of Warmth in the Hills of Nantou
-
2024.12.17 Glac Biotech × Public Good — Supporting Whole-Person Education and Building Dreams for the Next Generation